Investigational New Drug (IND) Application Accepted for EB-105 to Treat Diabetic Macular Edema
An Investigational New Drug (IND) application is a crucial part of the drug development process. INDs are requests submitted to the U.S. Food and Drug Administration (FDA) that authorize the…